CDSCO Archives

The expert panel of the CDSCO had recently approved antiviral drug Molnupiravir for restricted use in an emergency situation

Amid spike in COVID-19 cases, antiviral drug Molnupiravir launched in India

PGurus Newsdesk - January 4, 2022 0

Covid antiviral drug Molnupiravir launched in India The much-awaited antiviral pill against COVID-19, Molnupiravir was launched in India on Monday. Covid antiviral drug is priced...

COVID_19

Now 8 vaccines, 4 treatments in India’s fight against COVID-19

Team PGurus - December 28, 2021 0

CDSCO allows 12 ways to tread COVID-19 India’s drug regulator, The Central Drugs Standard Control Organisation (CDSCO) has granted restricted emergency use authorization to two...

Increasing the Covaxin shelf life helps reduce the carbon footprint, says the company

Health

Shelf life of Covaxin extended to 12 months from the date...

Team PGurus - December 20, 2021 1

Extended shelf-life for Covaxin helps lessen vaccine wastage The Central Drugs Standard Control Organisation (CDSCO) has approved the extension of Bharat Biotech's COVID-19 vaccine Covaxin's...

COVID_19

India’s own Bharat Biotech’s Covaxin granted restricted emergency use authorisation

Team PGurus - March 11, 2021 1

Covaxin has been moved out of the clinical trial mode The Government of India (GOI) on Thursday said Bharat Biotech's indigenously developed Covaxin has been...